Cargando…

NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

The prognostic significance of the major redox regulator nuclear factor erythroid-2-related factor (NRF2) is recognized in many cancers, but the role of NRF1 is not generally well understood in cancer. Our aim was to investigate these redox transcription factors in conjunction with redox-related mic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hämäläinen, Mari, Teppo, Hanna-Riikka, Skarp, Sini, Haapasaari, Kirsi-Maria, Porvari, Katja, Vuopala, Katri, Kietzmann, Thomas, Karihtala, Peeter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794976/ https://www.ncbi.nlm.nih.gov/pubmed/31687076 http://dx.doi.org/10.1155/2019/2647068

Ejemplares similares

NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma
por: Immonen, Anni, et al.
Publicado: (2022)

Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas
por: Karihtala, Peeter, et al.
Publicado: (2017)

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2022)

The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy
por: Roininen, Nelli, et al.
Publicado: (2017)

Mutational signatures and their association with survival and gene expression in urological carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2023)

Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
por: Teppo, Hanna-Riikka, et al.
Publicado: (2017)

Keap1 expression has independent prognostic value in pancreatic adenocarcinomas
por: Isohookana, Joel, et al.
Publicado: (2015)

Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP
por: Kari, Esa, et al.
Publicado: (2019)

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer
por: Jääskeläinen, Anniina, et al.
Publicado: (2018)

The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases
por: Häyrinen, Marjaana J., et al.
Publicado: (2023)

Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical study
por: Roininen, Nelli, et al.
Publicado: (2017)

Functional Role of NRF2 in Cervical Carcinogenesis
por: Ma, Jun-Qi, et al.
Publicado: (2015)

Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma
por: Kuusisto, Milla Elvi Linnea, et al.
Publicado: (2015)

The Yin and Yang of Nrf2-Regulated Selenoproteins in Carcinogenesis
por: Brigelius-Flohé, Regina, et al.
Publicado: (2012)

NRF2 and STAT3: friends or foes in carcinogenesis?
por: Arena, Andrea, et al.
Publicado: (2023)

A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies
por: Härkönen, Jouni, et al.
Publicado: (2023)

The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis
por: Occhiuto, Christopher J., et al.
Publicado: (2023)

Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma
por: Kuitunen, Hanne, et al.
Publicado: (2020)

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
por: Abdalkader, Moataz, et al.
Publicado: (2018)

Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma
por: Peroja, Pekka, et al.
Publicado: (2012)

Genetic Variants Associated With Sudden Cardiac Death in Victims With Single Vessel Coronary Artery Disease and Left Ventricular Hypertrophy With or Without Fibrosis
por: Vähätalo, Juha H., et al.
Publicado: (2022)

Effects of Nrf2 silencing on oxidative stress‐associated intestinal carcinogenesis in mice
por: Yokoo, Yuh, et al.
Publicado: (2016)

NRF2 Enables EGFR Signaling in Melanoma Cells
por: Kreß, Julia Katharina Charlotte, et al.
Publicado: (2021)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis
por: Cirone, Mara, et al.
Publicado: (2022)

The mutational signatures of cancer: can passengers set a direction for prognosis?
por: Karihtala, Peeter
Publicado: (2023)

NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
por: Carpenter, Evan L., et al.
Publicado: (2022)

The dual role of Nrf2 in melanoma: a systematic review
por: Malakoutikhah, Zahra, et al.
Publicado: (2023)

Chemoprevention of oxidative stress-associated oral carcinogenesis by sulforaphane depends on NRF2 and the isothiocyanate moiety
por: Lan, Aixian, et al.
Publicado: (2016)

Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanisms
por: Giudice, Aldo, et al.
Publicado: (2019)

Demethylation of the NRF2 Promoter Protects Against Carcinogenesis Induced by Nano-SiO(2)
por: Lou, Dan, et al.
Publicado: (2020)

Curcumin prevents As(3+)-induced carcinogenesis through regulation of GSK3β/Nrf2
por: Dang, Yuan-Ye, et al.
Publicado: (2021)

New Discoveries and Ambiguities of Nrf2 and ATF3 Signaling in Environmental Arsenic-Induced Carcinogenesis
por: Bi, Zhuoyue, et al.
Publicado: (2021)

NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5
por: Gurri, Selina, et al.
Publicado: (2023)

Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease
por: Ran, Caroline, et al.
Publicado: (2017)

Defining the Functional Targets of Cap‘n’collar Transcription Factors NRF1, NRF2, and NRF3
por: Ibrahim, Lara, et al.
Publicado: (2020)

Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
por: Peroja, Pekka, et al.
Publicado: (2018)

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
por: Cucci, Marie Angèle, et al.
Publicado: (2023)

Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis
por: Nair, S, et al.
Publicado: (2008)

Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
por: Carlson, Jennifer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uae0bthbd4inbu9ntm8i5tqlfo